Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for GLUCAGON
- The Effect of GIP, GLP-1 and GLP-2 in Individuals With Genetically Altered Receptor Function
- Renoprotective Effects of Dulaglutide in Patients With Type 2 Diabetic Nephropathy
- Insulin Degludec vs Insulin Glargine for Glycemic Control in Critical Illness Hyperglycemia
- GLP-1 Receptor Agonists Post-Bariatric Surgery (GRABS) Feasibility Trial
- A First-In-Human Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GUB014295
- ESG vs GLP-1RA vs ESG + GLP-1RA in Patients With Obesity, NAFLD and Advanced Fibrosis: A Randomized Controlled Trial
- Dexamethasone/Pancreatic Clamp P&F
- The Impact of Sitagliptin as an Add on Therapy With Closed Loop Control in Adolescents With Diabetic Nephropathy
- Acute and Chronic Effects of Oral Ketones in Subjects With HFrEF and Diabetes
- Weight-loss Drug for Fertility-Sparing Treatment of Atypical Hyperplasia and Grade 1 Cancer of the Endometrium
- A Fully Automated Lyumjev and Pramlintide Delivery System for Adults With Type 1 Diabetes
- Semaglutide Therapy for Alcohol Reduction (STAR)
- Liraglutide and Metformin Combination on Weight Loss, Metabolic - Endocrine Parameters and Pregnancy Rate in Women With PCOS, Obesity and Infertility
- The Efficacy, Mechanism & Safety of Sodium Glucose Co-Transporter-2 Inhibitor & Glucagon-Like Peptide 1 Receptor Agonist Combination Therapy in Kidney Transplant Recipients
- Does Semaglutide Reduce Alcohol Intake in Patients With Alcohol Use Disorder and Comorbid Obesity?
- A Study of LY3532226 in Participants With Type 1 Diabetes Mellitus
- Semaglutide and Vascular Regeneration
- Role of Semaglutide in Restoring Ovulation in Youth and Adults With Polycystic Ovary Syndrome
- Semaglutide in Nonalcoholic Fatty Liver Disease
- Semaglutide in CFRD
- Acute Hemodynamic Response to Carvedilol in Children With Clinically Significant Portal Hypertension.
- A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes
- Effect on Non-Alcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus With Gastric Inhibitory Polypeptide/Glucagon Like Peptide-1 Analogue
- Pharmacodynamics and Pharmacokinetics of Different Glucose Bead Formulations in Obese Healthy Subjects
- Pancreatic Clamp in NAFLD
- A Clinical Study to Evaluate the Effects of Akkermansia Muciniphila on Insulin Resistance Among Obese Subjects.
- Pharmacodynamics and Pharmacokinetics of 3 New Developed Coated Glucose Beads in 20 Obese Healthy Subjects
- A Study of Tirzepatide (LY3298176) to Assess Glycemic Control in Adults With Type 2 Diabetes Switching From a GLP-1 RA to Tirzepatide (SURPASS-SWITCH-2)
- Semaglutide Treatment for Hyperglycaemia After Renal Transplantation
- Effect of Gemigliptin Versus Glimepiride on Cardiac Diastolic Function in Patients With Type 2 Diabetes
- Effect of Thiamine on Serum Glucagon And Reactive Oxygen Species (ROS)
- Growth Hormone Deficiency in Mild Traumatic Brain Injury
- Tirzepatide Monotherapy in Patients With Wolfram Syndrome Type 1
- Semaglutide vs Metformin in Polycystic Ovary Syndrome (PCOS)
- Acute Subcutaneous SemaglutidE in Acute Ischemic sTroke
- Glucagon-like Peptide-1 Agonism With Very Low Calorie Diets
- Does the Hematopoietic Stem Cell Govern Residual Inflammatory Cardiovascular Risk in Type 2 Diabetes
- SITAgliptin Plus GLARgine to Glycemic Control in the Hospital Setting (SITAGLAR-H)
- Young Adults With Early-onset Obesity Treated With Semaglutide
- Semaglutide for the Treatment of Glucose Intolerance in Women With Prior Gestational Diabetes
- Effects of Semaglutide on Nicotine Intake
- Semaglutide for Alcohol Use Disorder
- Ultrarapid Insulin Administered by a Bihormonal Closed Loop System in Patients With Type 1 Diabetes
- The Effects of Glucagon on Hepatic Metabolism
- The Effects of Glucagon on Hepatic Metabolism in People With Type 2 Diabetes After Caloric Restriction
- Therapeutic Strategies for Microvascular Dysfunction in Type 1 Diabetes
- Dorzagliatin and 1st Phase Insulin and Beta-cell Glucose Sensitivity in IGT and NGT
- Geisinger Antibiotic Allergy Pilot Program: Assess and Address
- A Stable Glucagon Analog Administered by a Bihormonal Closed Loop System
- A Study of LY3537021 in Healthy Participants
- Vitamin D, K2 Plus Empagliflozin Combination in Type Two Diabetes Mellitus
- Examination of Bromocriptine on Homeostatic and Hedonic Mechanisms of Food Intake in Individuals at High Risk for T2DM
- Obesity Treatment to Improve Diabetes
- A Study to Evaluate Effects of KN056 in Healthy Subjects
- Low-Dose Glucagon and Advanced Hybrid Closed-Loop System for Prevention of Exercise-Induced Hypoglycaemia in People With Type 1 Diabetes
- A Phase 1, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single-and Multiple-Ascending Subcutaneous Doses of DR10624
- A Study of LY3457263 Alone and in Combination With Dulaglutide (LY2189265) in Participants With Type 2 Diabetes
- A Research Study on How NNC0487-0111 Works in People With Overweight or Obesity
- GLP-1 Analogue in Preventing Progression of Small Vessel Disease (GAP-SVD)
- Semaglutide in Comorbid Schizophrenia Spectrum Disorder and Obesity
- Analyse the Effect of Semaglutide on Vascular Structure and Function in Patients With Early Type 2 Diabetes
- Endoscopic Ultrasound Guided Gastric Botulinum Toxin Injections Versus Glucagon Like Peptide 1 Receptor Agonist in Weight Loss
- Glucagon Suppression by Hyperglycemia in the Presence and Absence of Amino Acid Infusion
- Effects of GLP1-RA on Ectopic Fat Deposition in Chronic Kidney Disease
- Glucagon-Like Peptide-1 Receptor Agonist in the Treatment of Adult, Obesity-related, Symptomatic Asthma (GATA-3)
- Basal Plus GLP1-ra on Glycemic Variability in CKD
- Semaglutide to Reduce Atrial Fibrillation Burden
- Stimulation Test With Intranasal Glucagon for Corticotroph, Somatotroph and Antidiuretic Axes
- Weekly Subcutaneous Semaglutide as Adjunct to Closed-loop Therapy in Type 1 Diabetes Care
- A Study in People With Obesity to Test the Effects of Different Doses of BI 456906 Compared With Liraglutide on Glucagon Receptor Activity in the Liver
- A Fully-closed Loop, Pramlintide and Insulin, Artificial Pancreas Clinical Trial for Adults With Type 1 Diabetes
- Home-based Intervention With Semaglutide Treatment Of Neuroleptica-Related Prediabetes
- XW004 To Evaluate the Safety, Tolerability, PK, and PD of Oral Ecnoglutide Tablet in Healthy Adults
- SGLT2 Inhibition in Hemodialysis
- Loxenatide Plus LNG-IUS in Endometrial Atypical Hyperplasia
- Concurrent Subcutaneous Basal Insulin and Intravenous Insulin Pump in Hyperglycemic Crisis Patients Under Critical Care
- Semaglutide Anti-Atherosclerotic Mechanisms of Action Study in Type 2 Diabetes Patients
- Pharmacogenetics of the Response to GLP-1 in Mexican-Americans With Prediabetes
- Effects of XW003 Versus Liraglutide on Body Weight of Adult Participants With Obesity
- Metabolic Adaptation to High-frequent Hypoglycaemia in Type 1 Diabetes
- Effect of Novel Glucagon Receptor Antagonist REMD-477 on Glucose and Adipocyte Metabolism in T2DM
- The Separate and Combined Effects of Long-term GIP and GLP-1 Receptor Activation in Patients With Type 2 Diabetes
- Low-dose Glucagon for Prevention of Exercise-Induced Hypoglycemia in People With Type 1 Diabetes
- Effect Of Semaglutide In Coronary Atheroma Plaque
- Effect of Using Dextrose-containing Intraoperative Fluid in Children
- Effect of Gene Polymorphisms on GLP-1 Receptor Agonists Response in Patients With T2DM
- [68Ga]Ga-HBED-CC-exendin-4 and [68Ga]Ga-NOTA-exendin-4 PET/CT Imaging in the Same Group of Insulinoma Patients
- Effect of ZT-01 on Glucagon During Hypoglycemia in Type 1 Diabetes Mellitus
- A Study of Nasal Glucagon (LY900018) in Pediatric Participants With Type 1 Diabetes
- The Clinical Application of 68Ga-NOTA-exendin-4 PET/CT in Detecting Insulinoma
- Effect of GLP-1 Receptor Agonists on Trabecular Bone Score and Visceral Adiposity in Postmenopausal Women With Type 2 Diabetes Mellitus.
- Dual-Hormone Closed-Loop Glucose Control in Adolescents With Type 1 Diabetes
- INSULIN THERAPY DE-INTENSIFICATION WITH iGlarLixi
- Exenatide for Treating Cocaine Use Disorder
- Comparison of Oral Semaglutide w/ Placebo- Treatment for Latino Adults w/T2 Diabetes Receiving Enhanced Lifestyle Care
- Identification and Clinical Relevance of an Oxytocin Deficient State (GLP1 Study)
- Does GLP-1RA Prevent Deterioration of Metabolic State in Prediabetic and Diabetic Patients Treated With Antipsychotic Medication?
- SeMaglutide and Albuminuria Reduction Trial in Obese Individuals Without Diabetes
- Liraglutide (Saxenda(R)) in Adolescents With Obesity After Sleeve Gastrectomy
- Liraglutide and Peripheral Artery Disease
- GLP-1 RAs in Patients With Polycystic Ovarian Syndrome (PCOS)
- Lifestyle Counseling and Medication for Adolescent Weight Management
- Perioperative Stress Hyperglycemia in General and Vascular Surgery Patients
- The Effect of Lifestyle-induced Hepatic Steatosis on Glucagon-stimulated Amino Acid Turnover
- Effect of Akkermansia Muciniphila WST01 Strain in Overweight or Obese Patients With Type 2 Diabetes
- Is Saxenda® a Viable Treatment of Obese Patients in Forensic Psychiatry?
- GLP-1 Analogue Effects on Food Cues, Stress, Motivation for Highly Palatable Foods, and Weight
- Effects of GRA in Patients With Type 1
- Efficacy of Liraglutide Therapy in Patients With IPAA
- Effect of Subcutaneous Semaglutide on Kidney Transplant Candidacy
- Glucagon Like Peptide 1 Receptor (GLP1R) Expression and Beta-cell Mass in Patients With Type 2 Diabetes
- GLP-1 Agonist Therapy in Cystic Fibrosis-Related Glucose Intolerance
- A Trial to Investigate Hyperglycemic and Hypoglycemic Excursions in Subjects With Type 1 Diabetes
- Effects of Glucagon-Like Peptide-1 Analogs on Sexuality
- Liraglutide Plus Megestrol Acetate in Endometrial Atypical Hyperplasia
- Liraglutide for Low-responders After Bariatric Surgery
- Combination GRA and SGLT-2i Treatment in Type 1 Diabetes
- Transition From Basal/Bolus to Once-weekly Subcutaneous Semaglutide and Basal Insulin in Patients With Type-2 Diabetes Mellitus
- Incretin and Treatment With Inhibition of Sodium-glucose Cotransporter-2 Combination Insights Into Mechanisms Implicated in Congestive Heart Failure: "NATRIURETIC" Trial
- Efficacy and Tolerance of Liraglutide for Weight Loss in Obese Type 2 Diabetic Hemodialysis Patients
- Brain Activation and Satiety in Children 2
- Effect of Gender Affirming Hormone Therapy on Glucose Metabolism
- The Effect of the Interaction of Glucagon and Insulin on Endogenous Glucose Production in Humans
- Low-dose Dasiglucagon for Prevention of Insulin-Induced Hypoglycemia in People With Type 1 Diabetes
- 16-week Flexible vs. 8-week Semaglutide Titration
- Study of the Pharmacologic Action of a GPR119 Agonist on Glucagon Counter-regulation During Insulin-induced Hypoglycemia in Type 1 Diabetes Mellitus
- The DPP-4 Inhibitor Vildagliptin as Adjunct in Major Depressive Disorder Patients
- GLP-1 Therapy: The Role of IL-6 Signaling and Adipose Tissue Remodeling in Metabolic Response
- Exercise and GLP-1 RA on Insulin Secretion
- Effect of Postprandial Insulin Administration of Faster-acting Insulin Analogue Versus Pre-prandial Administration of Acting-insulin Analogue in Cystic Fibrosis Related Diabetes
- Study to Assess the Efficacy and Safety of Liraglutide in the Treatment of Type 2 Diabetes
- The Effect of Sitagliptin Treatment in COVID-19 Positive Diabetic Patients
- Glucagon-like Peptide-1 in Type 1 Diabetes
- Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of JY09
- Glucagon Regulation of Glucose Metabolism
- The Effect of Curcumin on the Development of Prednisolone-induced Hepatic Insulin Resistance
- Effect of Glucagon and Glucagon-like Peptide-1 Co-agonism on Cardiac Function and Metabolism in Overweight Participants With Type 2 Diabetes
- Exenatide Treatment in Parkinson's Disease
- Effect of Physiologic Hyperglucogonemia on Adipocyte Metabolism
- Treatment of Patients With Teduglutide (GLP-2) for GVHD and Analysis of Paneth Cells of GVHD Patients
- Response of Gut Microbiota in Type 2 Diabetes to Hypoglycemic Agents
- Managing DIabetes Remission After Combined Therapy in EarLy Stage of DiabetEs
- The Effects of a Long-lasting Infusion of Vasoactive Intestinal Peptide (VIP) in Episodic Migraine Patients
- Co-administration of Pramlintide and Insulin Via an Automated Dual-hormone Artificial Pancreas System in Adults With Type 1 Diabetes
- Study to Explore the Effect of Dapagliflozin and Stress in Adolescent and Adult Subjects With Type 1 Diabetes (T1D)
- The Insulin Response to the Gut Hormone GIP After Near-normalisation of Plasma Glucose in Patients With Type 2 Diabetes
- The Effect of a SGLT2 Inhibitor on Glucose Flux, Lipolysis and Exercise in Type 2 Diabetes
- Micro Glucagon During Exercise in Type 1 Diabetes
- Clinical Evaluation of 68Ga-NOTA-MAL-Cys39-exendin-4 Positron Emission Tomography in the Detection of Insulinoma
- Incretin Hormones in Type 1 Diabetes Mellitus;Effect of Metformin Treatment
- Alleviating Carbohydrate Counting for Patients With Type 1 Diabetes Using a Novel Insulin-plus-pramlintide Artificial Pancreas
- Efficacy and Safety of Liraglutide in Type 2 Diabetes With Lower Extremity Arterial Disease
- Clinical Study on the Improvement of Diabetic Neuropathic Pain by Liraglutide
- Relationship Between Improvement in Insulin Secretion and Decrease in HbA1c in GLP-1 RA Therapy in T2DM Patients
- Combined Effects of GLP-1 Analogue and Exercise on Maintenance of Weight Loss and Health After Very-low Calorie Diet
- Glucagon Response to Prandial Insulin Administration in Persons With Type 1 Diabetes
- Inhibiting GABA Transaminase to Relieve Obesity Induced Hyperinsulinemia and Insulin Resistance
- Involvement of Dipeptidyl Peptidase-4 and Sodium-glucose Co-transporter-2 in Extrapancreatic Glucagon Secretion
- Renal Effects of Treatment With Empagliflozin Alone or in Combination With Semaglutide in Patients With Type 2 Diabetes and Albuminuria
- Dual-hormone Closed-loop Glucose Control in Type 1 Diabetes
- Dapagliflozin in Physical Exercise in Type 1 Diabetes
- Effect of Liraglutide on Microbiome in Obesity
- Transport of Satiety Factors Into the CSF
- Effects of Dapagliflozin on Hormonal Glucose Homeostasis in Type 1 Diabetes
- Metformin vs Metformin Combined With GLP-1RA (Glucagon-like Peptide 1 Receptor Agonist) on Overweight/Obese PCOS Patients
- Effects of SGLT2 Inhibitors on Islet Cell Function and Insulin Sensitivity in Patients of Type 2 Diabetes Mellitus
- Investigating Effects of BOTOX on Weight Loss and Glucose Tolerance in Obese, Type 2 Diabetic Subjects
- The Effects of a Long-lasting Infusion of Vasoactive Intestinal Peptide (VIP) on Headache, Cranial Hemodynamic and Autonomic Symptoms in Healthy Volunteers
- Comparing the Efficacy and Safety Between Short-term Continuous Subcutaneous Beinaglutide Injection and Continuous Subcutaneous Insulin Infusion (CSII) for Newly Diagnosed Type 2 Diabetes
- Dasiglucagon in the Treatment of Postprandial Hypoglycaemia After Roux-en-Y Gastric Bypass
- Mini-Dose Glucagon to Treat Fasting-induced Hypoglycemia During Ramadan
- Effectiveness of Dapagliflozin for Weight Loss
- The Effect of Glucagon on Rates of Hepatic Mitochondrial Oxidation in Man Assessed by PINTA
- Metabolic Responses of Dapagliflozin vs Sitagliptin in T2DM Patients Inadequately Controlled With Insulin Therapy
- Clinical Efficacy of Telmisartan in Reducing Cardiac Remodeling Among Obese Patients With Hypertension
- Liraglutide in Acute Minor Ischemic Stroke or High-risk Transient Ischemic Attack Patients With Type 2 Diabetes Mellitus
- Treating PCOS With Semaglutide vs Active Lifestyle Intervention
- Metabolic Pathways of GRA in Patients With Type 1 Diabetes
- Effect of Neprilysin on Glucagon-Like Peptide-1 in Patients With Type 2 Diabetes
- Dapagliflozin Plus Pioglitazone in T1DM
- The Physiological Effects of Human Ether-a-go-go-Related Gene (hERG)Blockade on Metabolism
- The Effect of Curcumin on Liver Fat Content in Obese Subjects
- Effects of Oral Glucose and Teduglutide on Plasma Lipoproteins
- A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Ascending, Subcutaneous, Single and Multiple Doses of SHP681 (Glucagon-like Peptide-2 [GLP-2] Analog-Fc Fusion) in Healthy Adult Participants
- Sodium-glucose Co Transporter 2 (sGLT2) Inhibitor and Endogenous Ketone Production
- Glucagon Ready-to-Use for the Prevention of Exercise-Induced Hypoglycemia During Aerobic Exercise in Adults With T1D
- Haemodynamic Effects of GLP-1 and Glucagon in Healthy Male Volunteers
- Prognostic Predictors of Response to Hypoglycemic Therapy
- Effect of Dapagliflozin Plus Low Dose Pioglitazone on Hospitalization Rate in Patients With HF and HFpEF
- Glucagon Ready to Use (RTU) in Subjects With Hyperinsulinemic Hypoglycemia After Bariatric Surgery
- A Study Comparing User Experience of Different Delivery Devices for Glucagon
- Metabolic Phenotyping During Stress Hyperglycemia in Cardiac Surgery Patients
- GLP-1-mediated Gluco-metabolic Effects of Bile Acid Sequestration
- G-Pen Compared to Glucagen Hypokit for Severe Hypoglycemia Rescue in Adults With Type 1 Diabetes
- Evaluation of the Safety, Tolerability and Bioavailability of Dasiglucagon Following Subcutaneous (SC) Compared to IV Administration
- The Effects of Neprilysin on Glucagon-like Peptide-1
- Therapeutic Approaches to Malnutrition Enteropathy
- Effects of Dapagliflozin+Saxagliptin in Addition to Metformin v/s Saxagliptin or Dapagliflozin in Patients With DM2.
- Effects of Empagliflozin on Endogenous Glucose Production in End Stage Renal Disease(ESRD).
- Daily Liraglutide for Nicotine Dependence
- Effects of Liraglutide on the Cognitive Function in Patients With Type 2 Diabetes Mellitus
- Dapagliflozin Effects on Hypoglycemia
- Effect of Glucagon-like Peptide 2 on Gallbladder Motility After a Meal in Young, Healthy Male Subjects
- Effects of GLP-1 RAs on Weight and Metabolic Indicators in Obese Patients
- Dulaglutide and Insulin MicrosecretiON in Type 1 Diabetes
- Insulin Treatment in Diabetic Older People With Heart Failure.
- Safety and Tolerability Study of MEDI0382 in Japanese Preobese or Obese Subjects With Type 2 Diabetes
- The Effects of Exenatide, a GLP-1 Agonist, on Alcohol Self-Administration in Heavy Drinkers
- The Gut Microbiome in Women With Polycystic Ovary Syndrome
- The Effect of Anesthesia on Perioperative Muscle Weakness and Neuro-endocrine Stress Response
- The Insulin-Only Bionic Pancreas Bridging Study
- Characterization of the Long-term Safety, Efficacy, and Pharmacodynamics Revestive® in the Management of Short Bowel Syndrome Pediatric Patients
- Understanding the Cardiovascular Benefits of the Anti-Diabetes Medication SGLT2 Inhibitors
- Brain and Gut Plasticity in Mild TBI Following Growth Hormone Therapy
- Carvedilol in Treating Hypoglycemia Unawareness
- Dapagliflozin During Exercise for the PrevenTion of Hypoglycaemia
- L-NMMA on GLP-2 Mediated Intestinal Lipoprotein Release
- Weight Loss With Intensive Lifestyle Modifications Plus Bariatric Surgery Versus Liraglutide 3 mg
- Glucagon's Cardiovascular Effects With and Without Beta-blocker-induced Cardioinhibition
- Hepatic Metabolic Changes in Response to Glucagon Infusion
- The Effect of Liraglutide on Pancreatic Hormones and Its Size
- Pasireotide in the Treatment of Hypoglycemia Following Gastric Bypass Surgery
- Glucagon-like Peptide-1 Metabolism and Acute Neprilysin Inhibition
- Vildagliptin on Gastric Accommodation
- Effects of LIraglutide on CArdiac Steatosis Evaluated by Magnetic Resonance Imaging
- Glucagon Infusion in T1D Patients With Recurrent Severe Hypoglycemia: Effects on Counter-Regulatory Responses
- Liraglutide 3mg (Saxenda) on Weight, Body Composition, Hormonal and Metabolic Parameters in Obese Women With PCOS
- The Efficacy of Sodium-glucose Co-transporter 2 Inhibitor or Dipeptidyl Peptidase-4 Inhibitor in Type 2 Diabetes Patients With Premix Insulin
- First Research Study to Compare a Possible New Medicine NNC9204-1513 to the Medicine Glucagon, in Healthy People.
- Effect of Exenatide LAR or Dulaglutide on the Variability of 24-hour Heart Rate and Blood Pressure in Type 2 Diabetes
- Glucagon-like Peptide-2 Mediated Secretion of Stored Enteral Lipids
- Study to Evaluate the Effect of Lixisenatide in Patient With Parkinson's Disease
- G-Pen™ Compared to Lilly Glucagon for Hypoglycemia Rescue in Adults With Type 1 Diabetes
- The Effects of Liraglutide on Sudomotor Function and Inflammation in Type 2 Diabetes
- Three Way Crossover Closed Loop Study With Xeris Glucagon
- Plasma Lipoprotein Response to Glucagon-like Peptide-2
- A Study of Nasal Glucagon (LY900018) in Japanese Participants With Diabetes Mellitus
- To Determine the Effect of GLP1 on Cognitive Function, Brain Glucose Metabolism and Neuroplasticity.
- Regulation of Endogenous Glucose Production by Brain Insulin Action in Insulin Resistance
- DECREASE: Dapagliflozin Plus Exenatide on Central REgulation of Appetite in diabeteS typE 2
- Sitagliptin and the Risk for Hypoglycaemia in Type 2 Diabetes Patients
- A Clinical Study to Investigate if SAR425899 Binds to the Liver and Pancreas in Overweight to Obese Type 2 Diabetes Mellitus Patients
- Evaluation of Liraglutide 3.0mg in Patients With Poor Weight-loss and a Suboptimal Glucagon-like Peptide-1 Response
- A Study of Nasal Glucagon in Participants With Type 1 Diabetes Mellitus
- Can Exenatide Prevent the Increase in EGP in Response to Dapagliflozin-induced Increase in Glucosuria
- Esophageal Food Impaction
- Once Weekly GLP-1 in Persons With Spinal Cord Injury
- Trial of EXenatide in Acute Ischaemic Stroke
- Liraglutide Effects on Epicardial Fat Inflammatory Genes
- Closed-Loop Glucagon Pump for Treatment of Post-Bariatric Hypoglycemia
- The Role of GLP-1 Receptor Signalling in the Glucose-lowering Effect of Metformin in Patients With T2D
- Liver Glycogen and Hypoglycemia in Humans
- Delineation of the Role of Glucagon-like Peptide-1 Signalling in Relation to Increased Carbohydrate Content in the Distal Small Intestines
- Does Treatment With GLP-1 Reduce Alcohol Intake in Patients With Alcohol Dependence?
- Efficacy of Glucagon In the Prevention of Hypoglycemia During Mild Exercise
- A Trial to Evaluate the Immunogenicity of Dasiglucagon and GlucaGen in Patients With Type 1 Diabetes Mellitus
- Acute Metabolic Effects of Melatonin Treatment
- Smoking Cessation Facilitated by Glucagon-like Peptide-1 (GLP-1) Analogues
- Intranasal Oxytocin vs. Placebo for the Treatment of Hyperphagia in Prader-Willi Syndrome
- Effects of Sequential Treatment Based on Lina/MET After Short-term Intensive Insulin in Newly Diagnosed Type 2 Diabetes
- Dapagliflozin and Hepatic Glucose Metabolism
- Dose Escalating Study of BPI-3016 in Healthy Subjects
- Stem Cell Mobilization (Plerixafor) and Immunologic Reset in Type 1 Diabetes (T1DM)
- A Trial to Investigate the Safety and the Pharmacokinetic, Pharmacodynamic Characteristics of Two BioChaperone® Glucagon Formulations Compared to Marketed GlucaGen® in Subjects With T1DM
- PROTOCOL 3: Role of the Renal Nerves in the Increase in EGP in Response to Glucosuria
- Bexagliflozin Drug/Drug Interaction Study With Exenatide Injection
- Effect of Exenatide on Cortisol Secretion
- Saxenda® in Obese or Overweight Patients With Stable Bipolar Disorder (Investigator Initiated)
- 21 Day Comparison of Continuous Insulin Infusion Using HDV Insulin to Standard Insulin in Type 1 Diabetes Mellitus
- Effects of Glucagon Like Peptide 1 (GLP-1) Analogues on Fluid Intake
- Effect of Prolonged (72 Hour) Glucagon Administration on Energy Expenditure in Healthy Obese Subjects
- Treatment Plan for an Individual Patient With Pasireotide for Hyperinsulinemic Hypoglycemia
- A Study to Identify Biomarkers of Hypoglycaemia in Patients With Type 2 Diabetes
- Cardiovascular Effects of GLP-1 Receptor Activation
- Glucose Response of G-Pen (Glucagon Injection) in Pediatric T1D Patients
- Impact of EMpagliflozin on Cardiac Function and Biomarkers of Heart Failure in Patients With Acute MYocardial Infarction
- Liraglutide-bolus vs Glargine-bolus Therapy in Overweight/Obese Type 2 Diabetes Patients (LiraGooD)
- The Effect of GIP and GLP-1 on Insulin and Glucagon Secretion in Patients With HNF1A-diabetes Treated With or Without Sulphonylurea
- Adrenergic System in Islet Transplantation
- Energy Balance Following Islet Transplantation
- Characterization of Metabolic and Brain Effects of Rising Glucagon During an Oral Glucose Challenge
- Pasireotide in Hyperinsulinemic Hypoglycemia
- Denosumab and Male Infertility: a RCT
- A Study of the Effect of Glucagon-like Peptide 1(GLP-1) Receptor Agonist in Combination With Metformin Therapy on Diabetes Remission in Subjects With Newly Diagnosed Type 2 Diabetes Who Are Overweight or Obese
- Meal-time Administration of Exenatide for Glycaemic Control in Type 1 Diabetic Cases
- A Study to Evaluate Pharmacokinetics, Safety and Efficacy of Albiglutide in Pediatric Subjects With Type 2 Diabetes Mellitus
- Safety and Efficacy of Umbilical Cord Blood Regulatory T Cells Plus Liraglutide on Autoimmune Diabetes
- Liraglutide as Additional Treatment to Insulin in Patients With Autoimmune Diabetes Mellitus
- Effects of Agonists of Glucagon Like Peptide - 1 Receptors (GLP-1R) on Arterial Stiffness, Endothelial Glycocalyx and Coronary Flow Reserve in Patients With Coronary Artery Disease and Patients With Diabetes Mellitus
- Paradoxical Stimulation of Hepatic Glucose Production With Dapagliflozin
- Effect of Dapagliflozin on Hepatic and Renal Glucose Metabolism Subjects
- Effect of Chronic Exenatide Therapy on Beta Cell Function and Insulin Sensitivity in T2DM
- Comparison of the Effectiveness and Tolerability of Exenatide Once-weekly Compared to Basal Insulins
- a Study of JY09 in Chinese Healthy Subjects
- Feasibility Trial Testing the Bionic Pancreas With ZP4207
- An Investigation Into the Effect of Dapagliflozin on Ketogenesis in Type 1 Diabetes
- Safety and Efficacy of Liraglutide in Parkinson's Disease
- Effectiveness & Tolerability of Novel, Initial Triple Combination Therapy vs Conventional Therapy in Type 2 Diabetes
- Delineation of the Diabetogenic Role of Extrapancreatic Glucagon in Totally Pancreatectomised Patients Using Glucagon Receptor Antagonism
- The Effect of Cinnamon Cassia on Diabetes Control and Cardiometabolic Risk Factors in Adults With Type 2 Diabetes Mellitus
- Weight Maintenance With Dipeptidyl Peptidase 4 (DPP4) Inhibitor Sitagliptin in Combination With Metformin After Liragludite Induced Weight Loss
- GLP-1 Signaling in Truncally Vagotomized Subjects
- CSI-Glucagon for Prevention of Hypoglycemia in Children With Congenital Hyperinsulinism
- Clinical Study of Liraglutide in Improving Cardiac Function for Patients With Ischemic Cardiomyopathy
- Effect of Anti-diabetic Drugs on Glycemic Variability
- Antigen-Lipid-Driven Monoclonal Gammopathies Targeting Epicardial Fat
- Subanalyses of Elderly Type 2 Diabetes Patients or Type 2 Diabetes Patients With Renal Impairment
- ZP4207(Dasiglucagon) Administered to T1D Patients to Assess the PK and PD Compared to Marketed Glucagon
- Preprandial Ghrelin Effect
- A Study to Demonstrate Bioequivalence Between Insulin Glulisine U300 and Insulin Glulisine U100 After a Single Subcutaneous Dose Using the Euglycemic Clamp Technique, in Patients With Type 1 Diabetes Mellitus
- GLP-1/Basal Insulin Combination Therapy
- Genetics of Response to Canagliflozin
- Study to Assess the Efficacy of Liraglutide in Patients With Type 2 Diabetes Mellitus
- Exenatide Plus Pioglitazone Versus Insulin in Poorly Controlled T2DM
- The Impact of Subcutaneous Glucagon Before, During and After Exercise a Study in Patients With Type 1 Diabetes Mellitus
- Treatment of Wolfram Syndrome Type 2 With the Chelator Deferiprone and Incretin Based Therapy
- Ox Bile- Conjugated Bile Acids Sodium in Type II Diabetes Mellitus
- Efficacy and Safety of Exenatide in the Treatment of Hypothalamic Obesity After Craniopharyngioma Therapy
- Prevention of Diabetes After Transplantation by Vildagliptin in the Early Post-transplant Period
- Long-acting Exenatide and Cognitive Decline in Dysglycemic Patients
- Closed-loop Control of Glucose Levels (Artificial Pancreas) for 15 Weeks in Adolescents and Adults With Type 1 Diabetes
- Stepping-down Approach in Patients With Chronic Poorly-controlled Diabetes on Advanced Insulin Therapy?
- The Effect of GLP-1 Receptor Agonist on Cerebral Blood Flow Velocity in Non-stroke Volunteers
- Metabolic Consequences of Gastrointestinal Surgery
- Short Term Effect of Liraglutide Versus Vildagliptine on Insulin Secretion and Insulin Sensitivity in Type 2 Diabetes
- Low dosE GlibENclamide in Diabetes Part A
- The Effect of GLP-1 Receptor Agonist on Cerebral Blood Flow Velocity in Stroke
- To Determine Tolerability to Glucagon Infusion in Obese Subjects
- The Bangladesh Environmental Enteric Dysfunction Study
- A Study of Single or Repeated Doses of Glucagon in Participants With Diabetes
- A Study of Single and Repeated Doses of Glucagon Administered to Participants With Diabetes
- A Study Comparing the Effect of Albiglutide With Exenatide on Regional Brain Activity Related to Nausea in Healthy Subjects
- SGLT-2 Inhibitor Empagliflozin Effects on Appetite and Weight Regulation.
- Safety of Overestimation of a Meal Insulin Bolus in the Context of Dual-hormone Closed-loop Operation - Part 2
- The Effect of Acipimox on GLP (Glucagon-like Peptide)-1 Secretion
- Double-blinded, 6 Months Study With Bydureon® or Placebo in Adolescents With Obesity to Explore Changes in BMI
- The Role of Glucagon in the Effects of Dipeptidyl Peptidase-4 Inhibitors and Sodium-glucose Co-transporter-2 Inhibitors
- Effect of Liraglutide on Clock Genes
- A Study of Glucagon Administered in Different Forms and Routes to Healthy Adults
- A Study of Nasal Glucagon in Participants With a Common Cold
- Effects of Single Doses of Liraglutide and Dapagliflozin on Hyperglycemia and Ketogenesis in Type 1 Diabetes
- Combination of Metformin/Inulin vs Inulin on Adiponectin in Metabolic Syndrome
- Efficacy, Tolerability and Pharmacokinetics of Subcutaneous Exendin (9-39) in Patients With Post Bariatric Hypoglycemia
- Effects of GLP-1 Analogues on Fluid Intake in Patients With Primary Polydipsia (The GOLD-Study)
- A Single-dose Cross-over Study to Assess Direct and Indirect Effects of Dapagliflozin on Pancreatic Alpha and Beta Cells in Patients With Type 2 Diabetes
- The Effect of Bitter Taste Receptor Agonists on The Gastrointestinal Tract, Hunger and Food Intake
- Feed-Back Suppression of Meal-Induced Glucagon-like Peptide 1 (GLP-1) Secretion
- In Vivo Assessment of Cellular Metabolism in Humans
- Glucagon Like Peptide-1 in Remote Ischemic Conditioning
- Liraglutide for HIV-associated Neurocognitive Disorder
- Assessment of Intranasal Glucagon on Endogenous Glucose Production
- Exenatide and Impaired Hypoglycaemic Awareness in Type 1 Diabetes
- Response of Individuals With Ataxia-Telangiectasia to Metformin and Pioglitazone
- Delivery of G-Pump™ (Glucagon Infusion) From an OmniPod® to Prevent Hypoglycemia in Post-Bariatric Surgery Patients
- Incretin Axis in Type 1 Diabetes Mellitus
- The iLet Introduction Study: A Feasibility Study of the iLet, a Fully Integrated Bihormonal Bionic Pancreas
- Intra-nasal Naloxone for Treatment of Impaired Awareness of Hypoglycemia
- Mechanisms Underlying Predictors of Success From Obesity Surgery
- A Single-dose, Dose-escalation Study of a Long-acting MOD-6031 in Healthy Overweight or Obese Subjects
- Gut Hormones in Obesity, Nicotine and Alcohol Dependence
- Safety and Efficacy Study of Albiglutide Liquid Drug Product in Type 2 Diabetes Mellitus
- DPP4 Inhibition & Beta Cell Function
- GLP-1 and Hyperoxia for Organ Protection in Heart Surgery
- Dissection of the Gastrointestinal-mediated Glucose Disposal and Incretin Defect in Patients With Type 2 Diabetes
- Energy Balance & Weight Loss in Craniopharyngioma-related or Other Hypothalamic Tumors in Hypothalamic Obesity
- Bioequivalence Study of Two Albiglutide Drug Products in Healthy Adult Subjects
- The Use of Mini-dose Glucagon to Prevent Exercise-induced Hypoglycemia in Type 1 Diabetes
- Effect of Liraglutide on Cardiovascular Endpoints in Diabetes Mellitus Type 2 Patients of South Asian Descent
- Single Doses of ZP4207 Adm. sc to Hypoglycemic TD1 pt. to Describe the PK and PD of ZP4207 as Comp. to Marketed Glucagon
- Safety and Efficacy of G-Pen Compared to Lilly Glucagon for Hypoglycemia Rescue in Adult Type 1 Diabetics
- Effect of Liraglutide on Diastolic Dysfunction on Cardiac MRI in Type 2 Diabetes Patients
- Comparing Effects of Liraglutide and Bariatric Surgery on Weight Loss, Liver Function, Body Composition, Insulin Resistance, Endothelial Function and Biomarkers of Non-alcoholic Steatohepatitis (NASH) in Obese Asian Adults
- Effects of GLP-1 on Chronic Heart Failure
- SGLT2 Inhibitor Versus Sulfonylurea on Type 2 Diabetes With NAFLD
- The Impact of Lixisenatide on Postprandial Glucose Tolerance in Pancreatectomised Subjects
- GLP-1 Mediating DPP-4 Inhibition in Type 2 Diabetes
- EQW, DAPA, EQW/DAPA, DAPA/MET ER and PHEN/TPM ER in Obese Women With PolycysticOvary Syndrome (PCOS)
- A Study to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of a Single Dose of SAR438544 in Comparison to Glucagon in Type 1 Diabetes Mellitus Patients Under Induced Hypoglycemia
- Safety of Overestimation of a Meal Insulin Bolus in the Context of Dual-hormone Closed-loop Operation
- A Study to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of Escalating Doses of SAR438544 in Comparison to Placebo and Glucagon in Healthy Subjects and Type 1 Diabetes Mellitus Patients
- Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetics (PKs) of ZYDPLA1 Following Oral Administration in Healthy Volunteers
- ESR-15-11293 - Saxa/Dapa, Safety and Efficacy Study
- Sitagliptin (DPP-4 Inhibitor) and NPH Insulin in Patients With T2D
- A Clinical Trial Analyzing Effects of Prokinetic Drug on the Blood Glucose in Patients With Type 2 Diabetes
- Glucagon-like Peptide-1 and Coronary Microvascular Dysfunction in Women With Angina Pectoris and no Coronary Stenosis
- SGLT2 Inhibition and Stimulation of Endogenous Glucose Production: Protocol 2
- Long-term Safety and Efficacy of Empagliflozin as Add on to GLP-1 RA
- The Effect of GLP-1 on Postprandial Glucagon Secretion Independent of The Gastric Emptying Rate
- GLP-1 on Non-ST-Segment Elevation Myocardial Infarction
- Effects of SGLT-2 Inhibition on Hepatic Glucose and Energy Metabolism
- Tofogliflozin GLP-1 Analogue Combination Trial
- A Euglycemic Insulin Clamp Study in Type 1 Diabetic Patients With Oral Insulin (ORAMED)
- Treatment of Hypoglycemia Following Gastric Bypass Surgery
- The Effect of VTC-G15 (a Pentapeptide Cleavage Product og GLP-1) on Whole Body Glucose Metabolism in Man
- Liraglutide in Adolescents With Type 1 Diabetes
- Effect of Ethanol Intoxication on the Anti-Hypoglycemic Action of Glucagon
- Bioavailability of Paracetamol, Amoxicillin and Talinolol Before, Immediately and One Year After Gastric Bypass Operation
- Effects of Glucagon Like Peptide-1 on No-reflow
- Glucose Response, Excursions And Treatment (GREAT) Study
- Effects of Incretin on the Blood Pressure and Lipid in Patients With Overweight or Obese Diabetes
- Alkaline Diet for Insulin Sensitivity
- The Clinical Study to Assess the Effect of the Amount of Carbohydrate Intake and Meals Differing in Glycemic Index (GI) in Patients Treated With a Sodium-dependent Glucose Cotransporter 2 (SGLT2) Inhibitor
- Effect of Metformin and Cholecystokinin-mediated Gallbladder Emptying on GLP-1 Secretion in Type 2 Diabetes
- Enhancing Weight Loss Maintenance With GLP-1RA (BYDUREON™) in Adolescents With Severe Obesity
- A Study Evaluating the Effect of Albiglutide on Gallbladder Emptying in Healthy Subjects
- Effects of Glucagon Like Peptide-1 on Haemodynamic Parameters
- Closed-loop Control of Postprandial Glucose Levels in Children and Adults With Type 1 Diabetes
- Saxagliptin and Cardiac Structure and Function
- Vildagliptin Versus Dapagliflozin on Glucagon
- The Effect of Liraglutide on Bone Turnover, Bone Mass and Bone Cell Function
- Psoriatic Arthritis Treated With Liraglutide Therapy: a QUality of Life and Efficacy Study
- Role of Preoperative Carbohydrates Drinks, Dichloroacetate and Exercise on Postoperative Muscle Insulin Resistance
- Linagliptin's Effect on CD34+ Stem Cells
- Saxagliptin's Effects on Microalbuminuria Improvement in Type 2 Diabetic Patients
- Safety and Efficacy of ZP-Glucagon to Injectable Glucagon for Hypoglycemia
- Effect of Short Term Atypical Antipsychotic Administration Compared to Placebo on Hepatic Insulin Extraction
- Research of Intensive Lifestyle Intervention for PCOS Patients With IGT
- Effect of Bile Acid Secretion and Sequestration on GLP-1 Secretion
- GLP-1 Analogs for Neuroprotection After Cardiac Arrest
- Comparative the Effect of Metformin and Acupuncture on Weight Loss and Insulin Sensitivity
- A Study of the Gut Barrier and Blood Vessel Inflammation in Individuals With and Without HIV
- G-Pen™ for Hypoglycemia Rescue in T1D Patients
- Closed-loop Control of Postprandial Glucose Levels in Adults With Type 1 Diabetes
- Multiple Ascending Dose Study in Healthy Male Subjects and Overweight to Obese Male and Female Type 2 Diabetes Mellitus (T2DM) Patients
- Mini-Dose Glucagon to Treat Non-Severe Hypoglycemia
- Investigating the Effect of Liraglutide on the Endogenous Glucose Production During in Tye 1 Diabetes Subjects
- Sitagliptin and Endothelial Dysfunction
- Pharmacokinetics and Pharmacodynamics of BIOD-961 vs. Marketed Glucagons
- Clinical Usability of Nasal Glucagon in Treatment of Hypoglycemia in Children and Adolescents
- Study on Exploring the Effect of DPP-4 Inhibitors on β-cell Function by Using the Two-step Hyperglycemic Clamp
- Exenatide Once Weekly, Cardiovascular Risk and Type-2 Diabetes
- Characterizing the Incretin Effect of Amino Acids and Defining GLP-1 Role on Skeletal Muscle
- Single Ascending Doses of ZP4207 Administered in HV and in T1D to Evaluate Safety, Tolerability PKs and PDs of ZP4207 Compared to a Comparator
- The Role of Phosphodiesterase Inhibitors in Incretin Secretion
- Effects of Linagliptin on Endothelial Function
- Dipeptidyl Peptidase-4 Inhibition and Narrow-band Ultraviolet-B Light in Psoriasis (DINUP)
- Impact of Pantoprazole on 24-H Glycemic Control and on Post-prandial Glucose Excursion in Patients With Type 2 Diabetes
- Dapagliflozin and Metformin,Alone and in Combination, in Overweight/Obese Prior GDM Women
- Influence of Gut Hormones on Food Intake After Roux-en-Y Gastric Bypass Surgery
- Effect of Intact GLP-1 (7-36) and GLP-1 Metabolite (9-36) on Coronary and Peripheral Vascular Function in Adults
- Randomized Trial Comparing Sitagliptin to Placebo in Closed Loop
- Effect of Combined Incretin-Based Therapy Plus Canagliflozin on Glycemic Control and the Compensatory Rise in Hepatic Glucose Production in Type 2 Diabetic Patients
- Effects of Sitagliptin on Gastric Emptying, Glycaemia and Blood Pressure in Type 2 Diabetes
- Combining Saxagliptin and Acarbose to Improve Postprandial Glycaemia in Type 2 Diabetes
- Comparison of Lobeglitazone With Pioglitazone as Initial Triple Therapy for Diabetes Management
- Liraglutide to Improve corONary Haemodynamics During Exercise streSS
- The Effect of Saxagliptin on Glucose Fluctuation and Immune Regulation in Patients With Type 1 Diabetes
- Hartmann's Solution and Normal Saline in Type II Diabetes Patients
- Saxagliptin in Combination With Dapagliflozin - Effects on Islet Cell Function
- Exenatide Compared With Insulin Glargine to Change Liver Fat Content in Type 2 Diabetes
- GLP-1 Agonism for Blocking Cocaine Euphoria and Self-Administration
- Effect of Cycloset on Glycemic Control When Added to Glucagon-like Peptide 1 (GLP-1) Analogue Therapy
- Determinants of Diabetes Remission After Gastric Bypass Surgery
- Effect of Linagliptin on TRL Metabolism
- Effect of LIXIsenatide on the Renal System
- Effect of Lixisenatide on Postprandial Lipid Profile in Obese Type 2 Diabetic Patients
- Sitagliptin and Glucagon Counterregulation
- Effects of DPP4 Inhibitor on Cisplatin Induced Acute Kidney Injury
- Metformin and Sitagliptin Therapy for Adult Patients With Type 2 Diabetes Admitted to the General Medical Unit
- Pathophysiological Study of the Increase in Pancreatic Volume in Type 2 Diabetes Treatments.
- Effects of Glucagon Administration on Energy Expenditure
- Insulinotropic Effect of GLP-1 and GIP After Dexamethasone
- Treatment of Low Blood Sugar With Glucagon Among Patients With Type 1 Diabetes
- The Practical Evidence of Antidiabetic Combination Therapy in Korea
- Single Dose Pharmacodynamic and Pharmacokinetic Study of DG3173
- Study of Tolerability and Safety of Adding Ustekinumab to INGAP Peptide for 12 Weeks in Adult Patients With TD1 Melitis
- Effect of Lixisenatide on Postprandial Plasma Glucose Compared to Sitagliptin in Combination With Insulin Glargine
- Correlation Between Plasma- and Endothelial DPP-4 Activity
- Therapeutic Efficacy of Triple Combination in Drug-naïve Korean Type 2 Diabetic Patients
- PDE-4 Inhibitor Roflumilast and GLP-1 Agonist Liraglutide in Polycystic Ovary Syndrome
- The Effect of Combination of Mosapride and DPP-4 Inhibitor on Plasma Concentration of Incretin Hormones
- A Prospective, Multicenter, Randomized, Open-label Study of 12 Week Duration to Evaluate the Effect of VILDagliptin Added to Insulin on Glycaemic Control in haemoDIALyzed Patients With Type 2 Diabetes: Probe Analysis of CGM
- Clinical Usability of Intranasal Glucagon in Treatment of Hypoglycemia
- Gastrointestinal Sensorimotor Dysfunctions in Diabetes Mellitus
- GLP-1 Agonism Stimulates Browning of Subcutaneous White Adipose Tissue in Obesity Men
- Phase IV Study With a 36-week Extension Period to Evaluate the Efficacy and Safety of Dapagliflozin Therapy When Added to the Therapy of Japanese Patients With Type 2 Diabetes With Inadequate Glycemic Control on Insulin.
- Vildagliptin vs. Glibenclamide in Endothelial Function in Type 2 Diabetes and Hypertension
- Regulation of Endogenous Glucose Production by Brain Insulin Action
- Natriuretic Effect of GLP-1in Healthy Non Obese Subjects
- The Effect of Glucagon-Like Peptide-1 (GLP-1) on Pulmonary Vascular Resistance (PVR) in Patients With Heart Failure
- A Dose-response of the Effects of Exendin-9,39 on GI Symptoms and Food Intake
- Cardioprotective Effects of GLP-1 and Their Mechanisms
- GLP-1 Loading During Elective Percutaneous Coronary Intervention
- Effects of Exercise and Inhibition of Dipeptidyl Peptidase-4 on Insulin Secretion in Subjects With Type 1 Diabetes
- Effects of GLP-1 Receptor Agonist on Fat Redistribution and Inflammatory Status
- Renal Effects of DPP-4 Inhibitor Linagliptin in Type 2 Diabetes
- Short Bowel Syndrome and Teduglutide Versus Placebo
- Effect of Repeated Administration of Liraglutide on Insulinogenic Indices
- Bioequivalence of Fresenius Kabi USA, LLC Glucagon for SC Injection Compared to Glucagon for Injection (Bedford Laboratories)
- GLP-1 Response and Effect in Individuals With Obesity Causing Genetic Mutations
- Safety and Efficacy Study of Mini-Dose Glucagon (G-Pen Mini) in Patients With Type 1 Diabetes
- PK/PD Study With G-Pump (Glucagon Infusion) in T1DM Patients
- Glucagon Use in Colonoscopies
- Effect of Bile Acid Sequestration on Postprandial GLP-1 Secretion, Glucose Homeostasis and Gut Microbiota
- Impact of Dopamine Infusion on Insulin Secretion in Healthy Subjects
- The Role of Metformin and Colesevelam in Human GLP-1 Secretion
- Effects of Liraglutide in Young Adults With Type 2 DIAbetes (LYDIA)
- Effect of GLP-1 Receptor (GLP-1R) Agonists on Cardiac Function and on Epicardial Adipose Tissue (EAT) Volume and on Myocardial TG Content in Obese Diabetics
- Perioperative Insulin, GIK or GLP-1 Treatment in Diabetes Mellitus
- Pilot Study Investigating the Feasibility of Determining the Endogenous Glucose Production During a Hypoglycaemia
- Effect of Saxagliptin on EPCs as a Cellular Biomarker for Evaluating Endothelial Dysfunction in Early T2DM Patients
- Saxagliptin + Metformin Compared to Saxagliptin or Metformin Monotherapy in PCOS Women With Impaired Glucose Homeostasis
- Study on Lixisenatide and Counterregulation to Hypoglycemia
- Equivalence of A Stable Liquid Glucagon Formulation With Freshly Reconstituted Lyophilized Glucagon
- Therapeutic Equivalence Between Branded and Generic WARFArin Tablets in Brazil
- Januvia (Sitagliptin) in Healing Chronic Diabetic Foot Ulcers
- Off taRget Effects of Linagliptin monothErapy on Arterial Stiffness in Early Diabetes
- A Study of MK-0893 on Glucagon-Induced Glycemic Excursion in Healthy Male Participants Following Intravenous Administration of Glucagon, Sandostatine® and Insulin (MK-0893-002)
- The Use of Glutamic Acid Decarboxylase (GAD) and Gamma-Amino Butyric Acid (GABA) in the Treatment of Type I Diabetes
- Efficacy Study of Glucagonlike Peptide-1 to Treat Reperfusion Injury
- Assessment of Intranasal Glucagon in Children and Adolescents With Type 1 Diabetes
- Efficacy and Safety of Nasal Glucagon for Treatment of Hypoglycemia in Adults
- Dipeptidyl Peptidase-4 Inhibition in Psoriasis Patients With Diabetes (DIP): A Randomized Clinical Trial.
- Safety Study of Repeated Doses of Glucagon on Animal Starch in the Liver
- A Phase I Study of 8-week Continuous Treatment With Polyethylene Glycol Loxenatide in Patients With Type 2 Diabetes
- A Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ZYD1, Following Subcutaneous Administration in Healthy Volunteers
- Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of G-Pen(TM) (Glucagon Injection) to Treat Severe Hypoglycemia
- Evaluation of 68Gallium-DOTATATE PET/CT for Detecting Neuroendocrine Tumors
- A PK/PD Study of Polyethylene Glycol Loxenatide in Patients With Type 2 Diabetes
- A Phase I Study of Polyethylene Glycol Loxenatide in Patients With Type 2 Diabetes
- Evaluate the Immunogenicity of a Novel Glucagon Formulation
- Regulation of Intestinal and Hepatic Lipoprotein Production by Glucagon Like Peptide 2
- Metformin's Effect on Glucagon-induced Glucose Production and Protein Metabolism.
- Effects of Xenin-25 on Insulin Secretion and Gastric Emptying in Humans With and Without a Complete Truncal Vagotomy
- Effect of Exenatide on Liver and Heart Fat and Inflammation
- Antidiabetic Effects of Adding a DPP-4 Inhibitor to Pre-Existing Treatment With an Incretin Mimetic in Patients With T2D
- ARA290 in T2D (Effects of ARA 290, an Erythropoietin Analogue) in Prediabetes and Type 2 Diabetes)
- Effect of Glucagon-like Peptide 1 (GLP-1) on Microvascular Myocardial Function in Patients With Type 2 Diabetes.
- DPP4inhibitors in Type 1 Diabetes
- Liraglutide Hospital Discharge Trial
- Trial to Compare the Relative Pharmacodynamic Properties of Different Glucagon Dosages
- Intestinal Glucagon-like Peptide-1 (GLP-1) and the Physiological Role in Eating in Humans
- Incretin Effect in PCOS Women
- Biphasic Insulin Aspart Versus NPH Plus Regular Human Insulin in Type 2 Diabetic Patients
- Splanchnic Blood Redistribution After Incretin Hormone Infusion and Obesity Surgery
- Effect of Chronic Incretin-based Therapy in Cystic Fibrosis
- Etiology, Assessment and Treatment of Post-gastric Bypass Severe Hypoglycemia
- Efficacy of Melatonin in Patients With Severe Sepsis or Septic Shock
- GLP-1 and Hypoglycemia
- Sitagliptin + Metformin Compared to Metformin Monotherapy and Placebo in Women With a Recent GDM
- Effect of Liraglutide on Automated Closed-loop Glucose Control in Type 1 Diabetes
- Study of the Acute Metabolic Effect of Exenatide in Type 1 Diabetes
- The Effect of Glucagon-like-peptide 1 (GLP-1) Receptor Agonism on Diabetic Kidney Disease
- Does a GLP-1 Receptor Agonist Change Glucose Tolerance in Antipsychotic-treated Patients?
- A Study to Evaluate the Safety and Effectiveness of DM199 in Healthy Subjects and Type 2 Diabetes Patients
- The Contribution of Incretin Hormones to Post-prandial Glucose Metabolism After Roux-en-Y Gastric Bypass
- The Contribution of Incretin Hormones to the Amelioration of Glucose Metabolism After Roux-en-Y Gastric Bypass
- A Study to Evaluate the Effect of Ranolazine on Postprandial Glucagon in Subjects With Type 2 Diabetes.
- Pramlintide (Symlin) for the Treatment of Hypoglycemia Following Gastric Bypass Surgery
- Effects of Linagliptin on Renal Endothelium Function in Patients With Type 2 Diabetes.
- A Pilot Study of the Effects on Sleep Disordered Breathing (SDB) When Using the Drug Liraglutide for 4 Weeks
- Efficacy of Small Subcutaneous Glucagon Dose to Treat Hypoglycemia in Adults With Type 1 Diabetes
- Exenatide on GI Motor Function and Permeability in Short Bowel Syndrome
- Pegvisomant With Glucagon Test to Assess for Adult Growth Hormone Deficiency
- Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
- Study of Glucagon, Ghrelin and Growth Hormone as Counterregulatory Hormones
- Treatment of Antipsychotic-associated Obesity With a GLP-1 Analogue
- Efficacy and Safety of a Glargine-based Hospital Discharge Algorithm in Coronary Artery Bypass Graft (CABG) Patients
- 52 Week Trial of Liraglutide in Type 1 Diabetes
- Liraglutide and a Calorie Restricted Diet Augments Weight Loss and Decreases Risk of Type 2 Diabetes and CVD.
- Effects of Exenatide on Obesity and/or Diabetes Mellitus Due to Hypothalamic Damage
- RISE Adult Medication Study
- Role of Interleukin-1 in the Regulation of Muscle Derived Interleukin-6 During Exercise
- Study to Understand the Genetics of the Acute Response to Metformin and Glipizide in Humans
- Effect of Liraglutide on Cardiovascular Endpoints in Diabetes Mellitus Type 2 Patients
- Effect of GLP-1 on Postprandial Lipid Metabolism
- Efficacy of Acarbose on Intestinal Microbiome and Incretins of Type 2 Diabetes
- Blood Pressure Outcomes With Liraglutide Therapy
- SAFEGUARD: Pleiotropic Effects of Incretin Based Therapies
- Sitagliptin in Type I Diabetic Patients
- GLP-1 and Microvascular Function in Type 2 Diabetes
- Influence of Appetite Related Hormones in Binge Eating Behaviour Among the Overweight and Obese
- Ghrelin Effect on Beta Cell Function in Health and Disease
- A Pilot Study to Determine the Effect of a Cobiotic Formulation on the Gastrointestinal Microbiome
- Liraglutide in the Treatment of Type 1 Diabetes Mellitus
- Liraglutide in Type 1 Diabetes
- Anti-diabetic Effects of Liraglutide in Adolescents and Young Subjects With Type 1 Diabetes
- Effect of Omeprazole on Metformin
- Effect of DPP4 Inhibition on Growth Hormone Secretion
- The Influence of Liraglutide on the Reward Properties of Food: an fMRI Study on Healthy Volunteers
- A Cohort Study of Incretin-based Therapy Combined With Insulin in Type 2 Diabetic Patients for 5 Years
- Testing State of the Art Remote Glucose Monitoring at Diabetes Camp
- The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and OAD Therapy
- Effect of Glucagon on Uterine Contractility at the Time of Embryo Transfer in in Vitro Fertilization
- Mechanisms of Improved Wound Healing and Protein Synthesis of Insulin and Metformin
- Effect of Bile Acids on GLP-1 Secretion
- Effects of Liraglutide on Kidney Function in Type 2 Diabetic Patients
- Roflumilast Plus Alogliptin Proof-of-Mechanism Study in Type2 Diabetes
- Study of Comparing the Different Effect of DPP-4 Inhibitors and Sulfonylurea by Using "Biphase-Hyperglycemic Clamp"
- The Impact of Gall Bladder Emptying and Bile Acids on the Human GLP-1-secretion
- A Single-dose Phase 1 Study of DBPR108 in Healthy Male Subjects
- Treatment With Sitagliptin in Non-obese Japanese Patients With Type 2 Diabetes Mellitus
- Study of LY2409021 in Participants With Type 1 Diabetes
- GLP-1 and Non-exercise Activity Thermogenesis in RHZ
- Eradication of Gut Microbiota
- Liraglutide in Type 1 Diabetes
- The Effects of GLP-1 in Maturity-Onset Diabetes of The Young (MODY)
- The Effect of LY2409021 on Blood Sugar Levels When Glucagon Levels Are Increased in Healthy Male Participants
- The Effect of Insulin on Protein Metabolism After Cardiac Surgery
- Sitagliptin Regulation of Intestinal and Hepatic Lipoprotein Particle and Hepatic Glucose Production in Humans
- Combinatorial Therapy for Peristent Type 2 Diabetes After Gastric Banding
- Pharmacodynamic Effects of Lixisenatide Compared to Liraglutide in Patients With Type 2 Diabetes Not Adequately Controlled With Insulin Glargine With or Without Metformin
- The Effect of Liraglutide on the Treatment of Coronary Artery Disease and Type 2 Diabetes
- A Long-term Trial to Compare the Effects of Liraglutide and Sulphonylurea (Glimepiride) Both in Combination With Metformin on Clinical, Endothelial and Image Markers of Cardiovascular Risk in Patients With Type 2 Diabetes
- GLP-1 Analogue Treatment in Uncontrolled Type 1 Diabetic Patients
- IGF-I Induced Muscle Glucose Uptake and Interstitial IGF-I Concentrations
- Myocardial Protection of Exenatide in AMI
- Safety and Dosing Study of Glucagon-like Peptide 2 (GLP-2) in Infants and Children With Intestinal Failure
- Evaluation of the Blood Levels of the Drug (Lixisenatide), the Plasma Glucose Levels and Safety in Paediatric and Adult Patients With Type 2 Diabetes
- Effect of GABA Supplementation in the Progression of Type 1 Diabetes in Children
- Evaluation of Vildagliptin (Galvus®) as add-on to Insulin in New-onset Type 1 Diabetes Mellitus
- Safety and Efficacy of a Novel Glucagon Formulation in Type 1 Diabetic Patients Following Insulin-induced Hypoglycemia
- Saxagliptin and Atherosclerosis
- Liraglutide Effects on Memory in Healthy Subjects
- Effect of Saxagliptin Treatment on Myocardial Fat Content, and Monocyte Inflammation
- Liraglutide Use in Prader-Willi Syndrome
- The Effect of Liraglutide Adjunct to Insulin on Glucagon Response to Hypoglycaemia in Subjects With Type 1 Diabetes
- Sitagliptin Dose Determination Study
- FLuctuATion Reduction With inSULin and Glp-1 Added togetheR (FLAT-SUGAR)
- Treatment of Diabetes After Gastric Bypass With Sitagliptin
- Effect of Liraglutide on Glucagon Secretion in Subjects With Type 2 Diabetes
- Study of Metabolic and Haemodynamic Effects of Metformin and Glimepiride in Patients With Type 2 Diabetes Mellitus
- The Effect of GLP-1 on the Inhibition of Glucagon Secretion
- Adding Liraglutide to High Dose Insulin: Breaking the Cycle
- Effects of the GLP-1 Exenatide on Satiety in Lean and Obese Women
- Study to Evaluate the Efficacy of Acarbose,Metformin,Sitagliptin Combination Treatment in DM Patients
- Physiologic Response to Glucagon at Varying Insulin Levels
- Efficacy and Safety of TAK-875 Compared to Glimepiride When Used With Metformin in Participants With Type 2 Diabetes
- Additional GLP-1 Analogue on CSII Treatment for Poorly Controlled Type 2 Diabetic Patients
- The Effect of Liraglutide on Left Ventricular Function in Chronic Heart Failure Patients With and Without Type 2 Diabetes Mellitus
- DPP IV Inhibition Facilitates Healing of Chronic Foot Ulcers in Type 2 Diabetes
- Identifying Potential Effects of Liraglutide on Degenerative Changes
- Effectiveness and Safety of Treatment of Insulin Glargine in Type 2 Diabetes Mellitus Following Glucagon-like Peptide-1 (GLP-1) Failure
- The Effect of Glucagon Like Peptide (GLP)-1 in Psoriasis
- Effect of Autonomic Neuropathy on the Efficacy of a DPP-IV Inhibitor (Galvus) Therapy
- Pharmacokinetics Study of Dipeptidyl Peptidase 4 Inhibitor to Control Type 2 Diabetes Mellitus
- The Role of Endogenous Glucagon-like Peptide 1 (GLP-1) in Type 2 Diabetes Mellitus (T2DM)
- Effects of Exenatide on Overweight Adolescents With Prader-Willi Syndrome
- The Effects of Bethanechol on Glucose Homeostasis
- Pramlintide Combined With Model Predictive Control Algorithm
- Effect Of Exenatide Treatment on Liver Fat Content in Patients With Diabetes
- Liraglutide and Heart Failure in Type 2 Diabetes
- Pharmacodynamics of Mitiglinide/Sitagliptin Compared to Mitiglinide and Sitagliptin
- The Effect of Vildagliptin Based Treatment Versus Sulfonylurea on Glycemic Variability, Oxidative Stress, GLP-1, and Endothelial Function in Patients With Type 2 Diabetes
- Liraglutide and Insulin Therapy in Patients With Type 2 Diabetes
- Pharmacokinetics and Pharmacodynamics Study of Alogliptin in Healthy Korean Participants
- Changes in Bone Turnover With Exposure to a GLP-1 Receptor Agonist
- Changes in Bone Turnover With Increased Incretin Hormone Exposure
- Evaluation of the Glucoregulatory Effects of Glucagon-like Peptide-1 Receptor (GLP-1 Receptor) Activation in Participants With Type 2 Diabetes Mellitus (MK-0000-222)
- Glucagon-like Peptide 1 Agonist Exenatide for Improved Glucose Control and Cardiac Function in Patients With Aortocoronary Bypass
- Impact of Exenatide on Cardiovascular Exercise Performance in Type 2 Diabetes
- Effects of Glucagon Like Peptide-1(GLP-1) and Liraglutide on Brain Satiety and Reward Circuits and Feeding Behavior in Diabetes
- VRS-317 in Adult Subjects With Growth Hormone Deficiency
- Mechanisms of Insulin Resistance in Critical Illness: Role of Systemic Inflammation and GLP-1
- Compare the Effect of DPP-IV Inhibitor or TZD on Glycemic Variability and Oxidative Stress in Patient With 2 Diabetes
- Efficacy and Safety of Ursodeoxycholic Acid (UDCA) Added to the DPP-4 Inhibitor in People With Type 2 Diabetes and Chronic Liver Diseases
- Metformin and Sitagliptin in Women With Previous Gestational Diabetes
- Sitagliptin and Kinetics of Triglyceride-rich Lipoproteins Apolipoprotein B48 and B100 in Patients With Type 2 Diabetes
- Effects of Saxagliptin on Endothelial Function
- Effect of LY2189265 on Insulin Secretion in Response to Intravenous Glucose
- The Effect of GLP-1 Receptor Activation on Central Reward and Satiety in Obesity and Diabetes
- Dipeptidyl Peptidase-4 Inhibitors and Alpha-cell Recovery
- JanUmet Before Insulin Lantus In Eastern Population Evaluation Program (JUBILEE) In Type 2 Diabetic Patients
- Use of Exenatide and Pramlintide to Decrease Post-prandial Hyperglycemia
- New Onset Type 1 Diabetes: Role of Exenatide
- Outpatient Discharge Therapy With Saxagliptin+MetforminXR vs GlipizideXL for Type 2 Diabetes With Severe Hyperglycemia
- Effect of Additional Treatment With EXenatide in Patients With an Acute Myocardial Infarction (the EXAMI Trial)
- Liraglutide Efficacy and Action in Non-Alcoholic Steatohepatitis
- Combined Liraglutide and Metformin Therapy in Women With Previous Gestational Diabetes Mellitus (GDM)
- Effects of Sitagliptin (Januvia®) on Blood Glucose Control in Patients With Type 1 Diabetes
- Vildagliptin and the Glucagon Response to Hypoglycemia in Insulin-Treated Patients With Type 2 Diabetes
- Dose-response Study of Exendin-9,39 on Glucose Metabolism
- Impact of Liraglutide on Endothelial Function and Microvascular Blood Flow in Type 2 Diabetes Mellitus
- Single-centre, Randomised, Double-blind, Placebo-controlled, Four-way Crossover Clinical Study to Investigate Safety and Tolerability and Pharmacokinetics of Single Doses of CM3.1-AC100 in Patients With Type 2 Diabetes
- Sitagliptin Therapy to Improve Outcomes After Islet Autotransplant
- Effect of GLP-1 on Glucose Metabolism in CNS Assessed by PET
- Intact Vagal Innervation and Glucagon-like Peptide-1 (GLP-1) Effects
- Intact Vagal Innervation for and Glucagon-like Peptide-1 (GLP-1) Effects
- Intact Liver Innervation and Glucose and Glucagon-like Peptide-1 (GLP-1) Induced Insulin Secretion
- Effects of Lixisenatide Compared to Liraglutide on the Postprandial Plasma Glucose in Patients With Type 2 Diabetes
- Role of Glucagon-Like Peptide-1 in Postprandial Hypoglycemia
- Protective Effects of Sitagliptin on β Cell Function in Patients With Adult-onset Latent Autoimmune Diabetes (LADA)
- Parenteral Nutrition Associated Liver Disease: Early Markers and Therapy Wih Enteral Omega-3 Supplementation
- Acute Regulation of Intestinal and Hepatic Lipoprotein Production by Glucagon
- The Role of GLP-1 in Satiety Perception in Humans
- Vildagliptin and the Glucagon Response to Hypoglycemia in Type 1 Diabetes
- Plasm Gastrin Concentrations in Response to Nexium Administration in Healthy Volunteers
- Somatostatin Analogue SOM230 (Pasireotide) in Healthy Male Volunteers
- The Vascular Effects of Vildagliptin in Insulin Resistant Individuals
- Early Insulin Treatment in Patients With Latent Autoimmune Diabetes
- Sitagliptin Versus Insulin Dose Increase in Type 2 Diabetes on Insulin Treatment
- Vascular Effects of Sitagliptin in Diabetes Mellitus
- Secretin-enhanced Magnetic Resonance Cholangiopancreatography (S-MRCP) and Pancreatic Function Following Surgery
- Effects of Exenatide on Hypothalamic Obesity
- Exenatide (Byetta ®) Regulation of Intestinal and Hepatic Lipoprotein Particle Production in Humans
- A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Doses of JNJ-38431055, Sitagliptin, and Co-administration of JNJ-38431055 and Sitagliptin
- Glucose-dependent Insulinotropic Polypeptide - New Role as Blood Glucose Stabilizer?
- Study Looking at Cardiovascular Effects of Exenatide, Its Blood Pressure Lowering Effect and Its Mechanisms
- Efficacy and Safety of Alogliptin Plus Metformin in Patients With Type 2 Diabetes
- Effects of Hyperglycemia on Myocardial Perfusion in Humans With and Without Type 2 Diabetes
- Effect of Angiotensin Receptor Blockade on Insulin Resistance and Adipose Tissue Cytokines in Type 2 Diabetes
- Effects of Growth Hormone on Cognition and Cerebral Metabolism in Adults With Growth Hormone Deficiency
- Vildagliptin and Endothelium-dependent Vasodilatation
- Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass Surgery
- Study to Evaluate the Effects of Colesevelam on Insulin Sensitivity and ß-Cell Function in Subjects With Impaired Fasting Glucose (Prediabetes)
- GLP-1 - Regulatory Mechanism of Postprandial Glycemia
- Assessing Glucose Effects of Sitagliptin (Januvia) in Adult Patients With Type 1 Diabetes
- 24-week Study Comparing Lixisenatide to Sitagliptin as add-on to Metformin in Obese Type 2 Diabetic Patients Younger Than 50 Years
- Galvus on Met Phase 4 Study : Study to Evaluate the Efficacy and Safety of Early Combination of Vildagliptin and Metformin in Patients With Type 2 Diabetes Mellitus
- Predictive Parameters for Efficacy of Sitagliptin and Metformin Combination
- Effect of Sitagliptin on Endothelial Progenitor Cells
- Glucose Insulin Potassium With Intensive Insulin Therapy and (GIK2) Versus GIK Alone
- Pharmacokinetics, Pharmacodynamics, and Safety of Alogliptin in Children, Adolescents and Adults With Type 2 Diabetes Mellitus
- The Effects of LAF237 on Gastric Function in Type 2 Diabetes
- The Effect of Byetta and Symlin on Post-meal Meal Blood Sugar Levels in Children With Type 2 Diabetes
- Xenin-25: Novel Regulator of Insulin Secretion and Beta-cell Function
- Dipeptidyl Peptidase-4 Inhibition on Glucagon-like Peptide-1 (GLP-1)
- Efficacy of Colesevelam in Subjects With Type 1 Diabetes Mellitus
- Glucagon Modulation of Ghrelin Secretion
- Endothelial and Metabolic Effects of Glucagon-like Peptide-1 (GLP-1) in Coronary Circulation in Patients With Type 2 Diabetes Mellitus
- Use of Exenatide and Pramlintide to Decrease Post-prandial Hyperglycemia
- Effect of Exendin-(9-39) on Fasting Adaptation and Protein Sensitivity
- Effects of Dipeptidyl Peptidase-4 (DPP-4) Inhibition on Hormonal Responses to Macronutrient Ingestion
- "Effect of Dipeptidyl Peptidase IV After Diets in näive Type 2 Diabetic Patients"
- Effectiveness of Oral Insulin in Unstable Type 1 Diabetes Patients
- Efficacy of GLP-1 Infusion in Comparison to an Insulin Infusion Protocol to Reach Normoglycemia Type 2 Diabetic Patients
- Glucagon-like Peptide 1 (GLP-1) and Endothelial Dysfunction in Metabolic Syndrome
- The Effects of Exenatide (Byetta ) on Energy Expenditure and Weight Loss in Nondiabetic Obese Subjects
- Pramlintide in Adolescents With Type 1 Diabetes
- Novel Therapy to Preserve Beta Cell Function in New Onset Type 1 Diabetes
- Pharmacological Postconditioning to Reduce Infarct Size Following Primary PCI
- Effect of Exendin (9-39) on Glucose Requirements to Maintain Euglycemia
- Comparison of the Effects of Repaglinide and Metformin on Glucose Excursions
- A Phase 1 Study to Evaluate the Safety and Tolerability of GSK1362885 in Healthy Normal Subjects
- Inhibition of Food Intake in Response to Oral GLP-1 and Peptide YY3-36
- Effects of Oral GLP-1 on Glucose Homeostasis and Appetite Profile in Healthy Male Subjects
- Mechanisms of Glucose Lowering Effects of Sitagliptin and Metformin Alone and in Combination in Patients With T2DM
- To Evaluate the Response to Glucagon During Hypoglycemia
- Assessment of the Effects of a DPP-4 Inhibitor (Sitagliptin) Januvia on Immune Function in Healthy Individuals
- Evaluating the Use of Exenatide in People With Type 2 Diabetes and Diastolic Heart Failure
- Study of the Effects of Xenin-25 in Humans With and Without Type 2 Diabetes Mellitus
- The Efficacy of Glucagon Like Peptide (GLP) - 1(7-36) Amide for Glycemic Control in Critically Ill Patients
- Sensor-Augmented Insulin Delivery: Insulin Plus Glucagon Versus Insulin Alone
- Incretin Effect in People With Impaired Fasting Glucose
- Is Insulin Resistance and/or Glucose Intolerance Pathogenetic in the Development of a Reduced Incretin Effect
- Effect of Exenatide, Sitagliptin or Glimepiride on Functional ß -Cell Mass
- Efficacy and Safety Study of SYR-619 in Treating Subjects With Type 2 Diabetes Mellitus
- Efficacy and Safety of SYR-472 in Subjects With Type 2 Diabetes Mellitus
- Safety and Efficacy Study of Alogliptin on Glycemic Control in Subjects With Type 2 Diabetes.
- The Effect of the GLP-1 Analogue Exenatide on Type 2 Diabetes in CNS and Heart During Hyperglycemia Assessed by PET
- How Improvement in Control of Diabetes Influences the Production of a Hormone Produced in the Gut Which Improves the Release and Action of Insulin.
- Pharmacokinetics (PK) and Pharmacodynamics (PD) of Mayne Glucagon for Injection Compared With Glucagen® (Novo Nordisk) in Healthy Volunteers
- Terlipressin + Albumin Versus Midodrine + Octreotide in the Treatment of Hepatorenal Syndrome
- Sitagliptin in Renal Transplant Recipients
- Exploratory Study of Additional Use of Scopolamine Butylbromide, Glucagon or NPO-11 Following Single Dose of NPO-11 in Healthy Adult Men
- Efficacy and Safety of TAK-379 in Adult Subjects With Type 2 Diabetes Mellitus
- Sitagliptin Prophylaxis for Glucocorticoid-Induced Impairment of Glucose Metabolism in Males With the Metabolic Syndrome
- GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Sulfonylurea
- GLP-1 Receptor Agonist Lixisenatide (Morning or Evening) in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Metformin
- The Effect of Sitagliptin on Hypertension, Arterial Stiffness, Oxidative Stress and Inflammation
- The Effect of Surgically Induced Weight Loss on Endocrine Function, Cardiovascular Function and Body Composition
- Mechanisms of Hypoglycemia Associated Autonomic Failure
- Effects of Glutamine on GLP-1 and Insulin Secretion in Man
- Effect of the Enteric Hormone Glucagon-Like Peptide (GLP-2) on the Intestinal Blood Flow in Patients With Short Bowel Syndrome
- Effect of Sitagliptin and an ACE Inhibitor on Blood Pressure in Metabolic Syndrome
- Efficacy of Alogliptin and With Pioglitazone in Patients With Type 2 Diabetes.
- Efficacy of SYR-472 in Subjects With Type 2 Diabetes Mellitus
- Effect of LAF237 on Glucagon Secretion in Patients With Type 2 Diabetes and in Healthy Subjects
- Milk as Treatment for Hypoglycemia
- Beta-Cell Function After Near-Normalisation of Blood Glucose
- Near Normalisation of BG Improves the Potentiating Effect of GLP-1
- Pioglitazone vs. Insulin Glargine in the Treatment of Secondary Drug Failure in Type 2 Diabetes
- Effect of GLP-1 on Insulin Biosynthesis and Turnover Rates
- GLP1R Polymorphisms and Response to GLP1
- Effect of Exendin-(9-39) on Glycemic Control in Subjects With Congenital Hyperinsulinism
- Effect of Sitagliptin on Incretin Effect in Patients With Type 2 Diabetes Mellitus
- Ghrelin in Healthy and Frail Older Women
- Sulfonylurea Effects on Glucagon Regulation During Hypoglycemia in Type 1 DM
- Efficacy of Pramlintide on Prevention of Weight Gain Early Onset of Type 1 Diabetes
- Effects of Sitagliptin on Gastric Emptying in Healthy Subjects
- Effect of Hyperglycemia on Gastric Emptying Interactions With Pramlintide
- A First in Human, Single Dose, Safety and Tolerability Study of MKC253 Inhalation Powder in Healthy Adult Males
- Insulin Secretion in Diabetes Before and After Glycemic Control
- Safety and Efficacy Study of Thalomid in Patients With Chronic Pancreatitis
- Effects of Exendin(9-39) on Gastroduodenal Motility
- A Titration Study of a Glucagon-Like Peptide-1 (GLP-1) Analogue in Patients With Type 2 Diabetes Treated With Metformin.
- Role of Exenatide in Type 1 Diabetes
- Post-meal Insulin Dosing With Adjuvant Pre-meal Pramlintide in Children With Type 1 Diabetes Mellitus
- Glucagon in the Treatment of Hypoglycemia in Newborn Infants of Diabetic Mothers
- Efficacy of Alogliptin and Pioglitazone in Subjects With Type 2 Diabetes Mellitus
- The Effect of GLP-1 on Glucose Uptake in the Brain and Heart in Healthy Men During Hypoglycemia
- Long Term Effects of DPP-IV Inhibitor Treatment in Patients With Type 2 Diabetes
- Efficacy of Alogliptin With Pioglitazone (Actos®) in Subjects With Type 2 Diabetes Mellitus
- Exendin(9-39)Amide as a Glucagon-like Peptide-1 (GLP-1) Receptor Antagonist in Humans
- Efficacy and Safety of Vildagliptin Versus Placebo in Patients With Type 2 Diabetes
- Medication, Weight Gain and GI Hormones
- Incretins in Impaired Fasting Glucose
- Controlled Study to Evaluate Efficacy and Safety of α-KA Tab With Low Protein Diet (LPD) in Delaying the Progress of Type 2 Diabetic Nephropathy (DN)
- 304-C03/L3301n: Effects of Growth Hormone on Glucose and Protein Metabolism in Children With Growth Hormone Deficiency
- Efficacy and Safety of Alogliptin Combined With Pioglitazone in Treating Subjects With Type 2 Diabetes Mellitus.
- Long-term Safety of Alogliptin in Patients With Type 2 Diabetes Mellitus
- A Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Activity of Very Low Dose-Glucagon in Subjects With Type 1 Diabetes Mellitus
- The Effects of L-arabinose on Intestinal Sucrase Activity in Man
- Continuous Subcutaneous Infusion of Pramlintide and Insulin
- Effects of Divalproex Sodium on Food Intake, Energy Expenditure, and Posture Allocation
- GLP-1 Infusion and Long-Time Fasting
- Randomized Evaluation of Octreotide Versus Compazine for Emergency Department Treatment of Migraine Headache
- The Importance of Glucagon-Like Peptide-2 (GLP-2)in Mesenteric Bloodflow in Humans
- Effect of 48 Hours of Treatment With the Natural Peptide-Hormone GLP-1 in Patients With Chronic Heart Failure
- The Effect of GLP-1 on Glucose Uptake in the Brain and Heart in Healthy Men
- Acute Metabolic Effects of LAF 237 in Type 2 Diabetics
- The Effect of Prolonged Pramlintide Infusion in Pediatric Diabetes
- The Role of Amylin and Glucagon in T1DM
- Polyclonal Anti-T-Lymphocyte Globulin (ATG) in Type 1 Diabetes
- Safety and Efficacy Study of Teduglutide in Subjects With Short Bowel Syndrome Who Completed Protocol CL0600-004 (NCT00081458)
- Intravenous-Morphine and Glucagon-Usage Enhanced MR Cholangiography
- Endocrine Dysfunction and Growth Hormone Deficiency in Children With Optic Nerve Hypoplasia
- Romidepsin in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors
- Safety and Efficacy Study of Teduglutide in Subjects With Short Bowel Syndrome
- Effect of AC2993 With or Without Immunosuppression on Beta Cell Function in Patients With Type I Diabetes
- NNC 90-1170 Mechanism of Action: A Double-Blind, Randomized, Single-Center, Placebo-Controlled, Crossover Study to Examine Beta-Cell Responsiveness to Graded Glucose Infusion in Subjects With Type 2 Diabetes
- Gluconeogenesis in Very Low Birth Weight Infants Who Are Receiving Nutrition By Intravenous Infusion
Clinical trials list
click for details